Rare DiseasesOrphan Drug ProductionCooperative BehaviorLymphangioleiomyomatosisPatient AdvocacyLithiasisBiomedical ResearchNational Institutes of Health (U.S.)Interinstitutional RelationsInterprofessional RelationsLegislation, DrugActinomycosisInternational CooperationDrug IndustryEuropean UnionPulmonary Alveolar ProteinosisDrug ApprovalAcademies and InstitutesPhysician-Nurse RelationsTomography, X-Ray ComputedInterdisciplinary CommunicationNeuroaxonal DystrophiesFatal OutcomeHistiocytosis, Langerhans-CellBirt-Hogg-Dube SyndromeHealth Level SevenPatient RightsBiological OntologiesPublic-Private Sector PartnershipsUnited StatesRetroperitoneal FibrosisUnited States Food and Drug AdministrationTranslational Medical ResearchHistiocytomaTreatment OutcomeUrea Cycle Disorders, InbornErdheim-Chester DiseaseEuropeEosinophilic GranulomaAngioedemas, HereditaryClinical Trials as TopicIron Metabolism DisordersMedical Laboratory PersonnelInternetEpidermolysis BullosaBreast Neoplasms, MaleTropherymaRegistriesSyndrome